Plant extract supplement for menopausal symptoms in women around menopause

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study is a randomized, double-blind, placebo-controlled trial enrolling about 120 women in Elche, Spain. Participants will take the plant extract supplement or a placebo daily for 12 weeks after a short screening, with six in-person visits. Researchers will track hot flashes, night sweats, menopausal symptoms, quality of life, sleep, mood, body composition, and various lab markers. Data will be collected from diaries, questionnaires, physical measurements, and blood tests at baseline and end of the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women aged 42 to 60 years.
* Late perimenopause or early postmenopause.
* Amenorrhea for at least 3 months and no more than 10 years since menopause.
* At least five moderate or severe hot flashes per day during the screening period.
* Body mass index of 35 kg/m² or less.
* Written informed consent.

Exclusion Criteria:

* Serious uncontrolled diseases.
* Treatments that may interfere with the assessment of the primary outcome measures.
* Known allergy or intolerance to any component of the study product.
* Concurrent participation in another clinical trial.
* Any circumstance that, in the investigator's judgment, would hinder compliance with the study protocol.

Where it's running

• European Institute Of Exercise and Health
  Elche, Alicante, Spain Recruiting

Study contacts

• Study coordinator: Alejandro Martínez Rodríguez
• Email: amartinezrodriguez@ua.es
• Phone: 696210163

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Hop extract vs soy isoflavone for menopausal symptoms

  This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.

  Recruiting Menoclinica by Palacios · Madrid, Madrid · NCT07904390

• Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety

  Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.

  Recruiting Konya Beyhekim Training and Research Hospital · Konya, Konya · NCT07860645

• Fezolinetant to reduce hot flashes in men on androgen-deprivation therapy

  This trial will test whether taking fezolinetant once daily for 4 weeks reduces how often and how severe hot flashes are in men with prostate cancer who are on androgen-deprivation therapy.

  Recruiting Phase 2 Brigham and Women's Hospital · Boston, Massachusetts · NCT06957691

• Understanding immune clues to depression in perimenopause

  This study tests whether immune and epigenetic changes during perimenopause help explain why some women develop depression.

  Recruiting at 3 sites Van Andel Research Institute · Grand Rapids, Michigan and 3 other locations · NCT07910552

• Shatavari-based herbal extract to help menopausal symptoms

  This study tests whether an 8-week daily herbal extract containing Shatavari can reduce menopausal symptoms in postmenopausal women, compared with a placebo.

  Recruiting India Glycols Ltd · New Port Richey, Florida · NCT07834463

• Can fezolinetant reduce hot flashes for Indian women going through menopause

  This study tests whether fezolinetant can lessen hot flashes and night sweats in Indian menopausal women who have persistent vasomotor symptoms.

  Recruiting Phase 3 Astellas Pharma Inc · Bengaluru, Karnataka · NCT07829653

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.